Australia markets closed

Krystal Biotech, Inc. (KRYS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
159.67+6.55 (+4.28%)
At close: 04:00PM EDT
159.00 -0.67 (-0.42%)
After hours: 04:49PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
10,932
10,932
-139,975
-69,570
-32,167
Depreciation & amortisation
5,007
5,007
2,643
1,849
1,851
Stock-based compensation
39,933
39,933
33,230
15,319
3,272
Change in working capital
-37,882
-37,882
2,811
2,506
917
Accounts receivable
-42,040
-42,040
0
0
-
Inventory
-4,475
-4,475
0
0
-
Accounts payable
-101
-101
-1,254
712
783
Other working capital
-100,603
-100,603
-153,548
-116,274
-40,926
Other non-cash items
-451
-451
-192
1,038
11
Net cash provided by operating activities
-88,804
-88,804
-100,569
-47,938
-26,083
Cash flows from investing activities
Investments in property, plant and equipment
-11,799
-11,799
-52,979
-68,336
-14,843
Purchases of investments
-508,776
-508,776
-318,781
-190,462
-3,205
Sales/maturities of investments
503,213
503,213
257,677
32,028
6,867
Other investing activities
100,000
100,000
-
-
-
Net cash used for investing activities
82,638
82,638
-114,083
-226,770
-11,181
Cash flows from financing activities
Common stock issued
203,499
203,499
35,996
355,645
118,019
Other financing activities
-749
-749
-649
-7,960
-
Net cash used provided by (used for) financing activities
202,750
202,750
35,347
347,685
118,019
Net change in cash
196,428
196,428
-179,346
72,977
80,755
Cash at beginning of period
161,900
161,900
341,246
268,269
187,514
Cash at end of period
358,328
358,328
161,900
341,246
268,269
Free cash flow
Operating cash flow
-88,804
-88,804
-100,569
-47,938
-26,083
Capital expenditure
-11,799
-11,799
-52,979
-68,336
-14,843
Free cash flow
-100,603
-100,603
-153,548
-116,274
-40,926